Kimberly LovettRockwell M.D.

Associate

Detroit + 1.313.230.7971

Connect:

Share

Dr. Kimberly Lovett Rockwell's experience as a board certified physician informs her approach to providing health care legal, regulatory, and compliance counsel to health care and non-health care entities. Throughout the COVID-19 (coronavirus) public health crisis, she has advised large corporate clients on policies and procedures for temperature screening, face covering, COVID-19 testing, and return-to-work protocols. She has also advised health care clients looking to expand telehealth programming in response to the COVID-19 crisis.

Kimberly advises clients on a range of state and federal legal and regulatory issues, including health care fraud, waste, and abuse laws and investigations arising under the False Claims Act (FCA), the Anti-Kickback Statute (AKS), civil monetary penalties, and fee-splitting laws; U.S. Food and Drug Administration (FDA) regulations; compliance program organization and implementation; telehealth and digital health practice structuring, restrictions, and reimbursement; supervision of non-physician providers; and corporate practice of medicine prohibitions.

Kimberly has held academic appointments at Stanford University and the University of California, San Diego and has given lectures on myriad health policy issues, including telehealth reform, health care reform, Medicare reform, and quality measurement. She has published book chapters and articles in peer-reviewed journals, including the Journal of the American Medical Association and Nature Reviews Cancer. Kimberly has served on the board of directors for the Michigan State Medical Society and the San Diego County Medical Society and also has served on numerous committees for the California Medical Association. She is a long-standing member of the American Medical Association and continues to serve primary care patients.

Experience

  • Digital health company expands telehealth programming in response to the COVID-19 public health crisisJones Day represented a digital health company in the expansion of their telehealth programming in response to the COVID-19 public health crisis.
  • National diagnostic clinician network expands telehealth programming in response to COVID-19 public health crisisJones Day represented a national diagnostic clinician network in their expansion of telehealth programming in response to the COVID-19 public health crisis.
  • Telehealth company expands programming in response to COVID-19 public health crisisJones Day represented a telehealth company in the expansion of their telehealth programming in response to the COVID-19 public health crisis and related health regulatory and contracting matters.
  • Telemedicine provider expands telehealth programming in response to COVID-19 public health crisisJones Day represented a telemedicine provider in their expansion of telehealth programming in response to the COVID-19 public health crisis.
  • Integer Holdings Corporation develops employee programming to mitigate the spread of COVID-19 within the workplaceJones Day represented Integer Holdings Corporation during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • Large critical infrastructure employer considers implementing COVID-19 testing program for employeesJones Day represented a large critical infrastructure employer during the COVID-19 crisis to consider and assess appropriate protocols and policies for implementing an employee COVID-19 testing program at its sites. This included counseling on myriad federal, state, and local legal and regulatory frameworks as well as forming appropriate partnerships.
  • Luxury department store chain develops employee programming to mitigate spread of COVID-19 within workplaceJones Day represented a luxury department store chain during the COVID-19 crisis to develop appropriate protocols and policies for implementing an employee temperature screening program, a face covering program, work from home and return to work policies for employees suffering from COVID-19, respiratory illness, or exposure to individuals with COVID-19.
  • Large critical infrastructure employer develops and implements protocol for international relocation of essential workers during COVID-19 pandemicJones Day represented a large critical infrastructure employer during the COVID-19 crisis to develop appropriate protocols and policies for the international relocation of several employees in accordance with CDC guidelines.
  • National digital health company launches government partnershipJones Day advised a large digital health company with multi-clinical services in negotiating a partnership with a state government program to provide telehealth and telemedicine consults during the COVID-19 state of emergency.
  • Large health care system investigates and voluntarily discloses clinical trial compliance concerns to federal agencyJones Day represented a large health care system in internal investigation, self-disclosure, and revision of company policies related to allegations of clinical trial noncompliance.
  • Leading specialty telemedicine organization launches novel telemedicine-oriented revenue cycle management offeringJones Day provided health regulatory counsel to one of the Nation’s leading specialty telemedicine organizations for its innovative reimbursement, enrollment, contracting, compliance policies, data privacy, and billing arrangements regarding specialty telemedicine services across the U.S.
  • Large multi-state corporation reviews compliance with state corporate practice of medicine laws and regulationsJones Day advised a private multi-state corporation on compliance with corporate practice of medicine laws and regulations in multiple states with respect to the corporation's employed health care practitioners providing clinical services to the corporation's employees.
  • Medical device manufacturer secures declination and dismissal of FCA complaint without any settlement paymentJones Day represented a medical device manufacturer in a False Claims Act case involving whether the company violated the Federal Anti-Kickback Statute.
  • Emerging digital health company launches multi-state telehealth platformJones Day advised an emerging digital health company in launching its telehealth operations in multiple states throughout the U.S., with additional expansion to come.
  • Large digital health company grows operations across U.S.Jones Day advised a large digital health company in expanding operations throughout multiple states in the U.S. and in responding to several state regulator inquiries regarding its operations.
  • Smith & Nephew acquires Rotation Medical Inc. for up to $210 millionJones Day advised Smith & Nephew plc in its acquisition of Rotation Medical Inc., a developer of a novel tissue regeneration technology for shoulder rotator cuff repair, for an initial cash consideration of $125 million and up to $85 million over the next five years, contingent on financial performance.
  • Emerging digital health company expands operations to new telehealth servicesJones Day advised an emerging digital health company in expanding its telehealth product offerings to patients across the United States and in responding to several state regulator inquiries regarding its operations.
  • Nonprofit hospital enters co-management agreement with physician group for oncology service lineJones Day represented a nonprofit health system in negotiating and drafting a co-management agreement with physician group for oncology services at one of its subsidiary hospital's inpatient facility and outpatient locations.
    • View All

    August 2020 Commentaries

    Emerging Testing Technologies Offer Potentially Significant Improvements for COVID-19 Screening Programs

    July 2020 Newsletters

    Vital Signs: Digital Health Law Update | Summer 2020

    April 2020 Newsletters

    Vital Signs: Digital Health Law Update | Spring 2020

    March 2020 Commentaries

    Telemedicine and COVID-19: CMS Touts Virtual Check-Ins, Has Authority to Implement Telehealth Waivers

    March 2020 Commentaries

    States Relax Physician Assistant Supervision and Delegation Laws

    March 2020 Commentaries

    Telemedicine and the Coronavirus Crisis: Key Legal Issues for Providers to Consider

    February 2020 Commentaries

    Newly Proposed AKS and Stark Law Protections For Value-Based Care Models

    February 2020 Commentaries

    Proposed Revisions to Stark Law and AKS Protections for Electronic Health Records Donations

    January 2020 Commentaries

    CMS Proposes New Limitations to the Isolated Transactions Exception to the Stark Law

    January 2020 Commentaries

    OIG Proposes Modifications to Personal Services Safe Harbor Under the AKS
    View All

    Additional Publications

    • November 2018
      Emergency Telemedicine: Achieving and Maintaining Compliance with the Emergency Medical Treatment and Labor Act, Telemed J E Health, 2018 Nov;24(11):934-937.
    • November 2018
      Emergency Telemedicine: Achieving and Maintaining Compliance with the Emergency Medical Treatment and Labor Act. Telemed J E Health. 2018 Nov;24(11):934-937

    Speaking Engagements

    • May 27, 2020
      Telemedicine and the Future of Medicine
    • April 2020
      Dr Kimberly Rockwell and Alexis Gilroy Discuss the Promise of Telemedicine for COVID-19 and Beyond, American Journal of Managed Care Newsroom
    • July 25, 2018
      Telehealth and Non-Physician Providers: Explore the types of Non-Physician Providers, Scope of Practice and Utility along with typical state supervision requirements and delegation restrictions.
    • March 19, 2018
      Contracting for Physicians: Pointers, Pitfalls, and Prohibitions, Beaumont Hospital
    • November 2, 2017
      Telemedicine: Evidence, Barriers, and Promises - Internal Medicine Grand Rounds, UIC Advocate Christ Medical Center
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.